rs150912462
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001010867.4(IBA57):c.1033G>A(p.Ala345Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000308 in 1,595,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A345S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001010867.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IBA57 | NM_001010867.4 | c.1033G>A | p.Ala345Thr | missense_variant | 3/3 | ENST00000366711.4 | |
IBA57 | NM_001310327.2 | c.454G>A | p.Ala152Thr | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IBA57 | ENST00000366711.4 | c.1033G>A | p.Ala345Thr | missense_variant | 3/3 | 2 | NM_001010867.4 | P1 | |
IBA57 | ENST00000484749.5 | n.3033G>A | non_coding_transcript_exon_variant | 3/3 | 5 | ||||
IBA57 | ENST00000546123.2 | n.753G>A | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.000223 AC: 34AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000207 AC: 49AN: 237068Hom.: 0 AF XY: 0.000164 AC XY: 21AN XY: 127888
GnomAD4 exome AF: 0.000317 AC: 457AN: 1443240Hom.: 0 Cov.: 32 AF XY: 0.000303 AC XY: 217AN XY: 715702
GnomAD4 genome ? AF: 0.000223 AC: 34AN: 152362Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74506
ClinVar
Submissions by phenotype
Multiple mitochondrial dysfunctions syndrome 3;C5568837:Hereditary spastic paraplegia 74 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Nov 27, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 345 of the IBA57 protein (p.Ala345Thr). This variant is present in population databases (rs150912462, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with IBA57-related conditions. ClinVar contains an entry for this variant (Variation ID: 572919). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | The c.1033G>A (p.A345T) alteration is located in exon 3 (coding exon 3) of the IBA57 gene. This alteration results from a G to A substitution at nucleotide position 1033, causing the alanine (A) at amino acid position 345 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 11, 2023 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at